| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 13.86B | 5.40B | 4.96B | 4.50B | 7.46B |
| Gross Profit | 7.56B | 5.40B | 4.96B | 6.88B | 6.01B |
| EBITDA | 2.69B | 2.93B | 2.00B | 2.41B | 2.51B |
| Net Income | 2.06B | 1.67B | 1.59B | 1.22B | 1.31B |
Balance Sheet | |||||
| Total Assets | 270.38B | 266.52B | 269.79B | 259.85B | 256.53B |
| Cash, Cash Equivalents and Short-Term Investments | 17.84B | 15.67B | 21.02B | 21.43B | 16.85B |
| Total Debt | 4.93B | 4.15B | 8.89B | 8.45B | 4.13B |
| Total Liabilities | 223.89B | 223.33B | 228.79B | 222.69B | 218.70B |
| Stockholders Equity | 37.49B | 34.64B | 32.68B | 29.52B | 30.19B |
Cash Flow | |||||
| Free Cash Flow | 2.80B | 4.05B | -2.10B | 5.36B | 3.69B |
| Operating Cash Flow | 2.80B | 4.40B | -2.10B | 5.54B | 3.93B |
| Investing Cash Flow | -182.05M | -43.53M | -44.88M | -38.60M | -93.54M |
| Financing Cash Flow | -1.42B | -7.98B | 962.65M | 2.95B | 1.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$18.60B | 6.06 | 7.04% | 6.54% | -9.67% | 20.16% | |
74 Outperform | HK$13.49B | 3.57 | 5.58% | 6.53% | -7.31% | 22.84% | |
71 Outperform | HK$498.61B | 5.80 | 11.37% | 5.80% | -1.26% | 4.94% | |
70 Outperform | HK$484.37B | 4.85 | 9.18% | 5.76% | -3.89% | 2.20% | |
70 Outperform | HK$1.09T | 7.29 | 11.91% | 4.26% | -4.57% | 1.77% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | HK$37.12B | 8.05 | 3.26% | 5.78% | -12.22% | -19.99% |